Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Strategic Partnership
Sort By
Newest First
Sign in
1 / 6
1 / 6
Announcement
Inceptor Bio and GRIT Bio Cooperate to Advance IB-T101, a Next-Generation Solid Tumor CAR-T Utilizing the OUTLAST™ Platform
Inceptor Bio
PR-12-24-NI-142
Dec 18, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01
Aug 07, 2024
CDMO Model
Rethinking the Conventional CDMO Model
Wheeler Bio
PAO-08-24-CL-04
Jul 29, 2024
Regulatory
Building a Path to Approval with Effective Regulatory Support
Mira Han
Samsung Biologics
PAO-07-24-CL-12
Jul 29, 2024
CDMO Selection
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
Scorpius BioManufacturing
PAO-11-23-CL-04
Dec 08, 2023
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
Samsung Biologics
PR-M10-23-06
Oct 24, 2023
CDMO Partnerships
Webinar: A Developer's Guide to Partnering With the Right CDMO, Presented by Samsung Biologics
Samsung Biologics
PAO-08-23-PATV-01
Aug 16, 2023
CDMO Partnerships
Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market
Daniel Buckley
Samsung Biologics
PAO-05-23-CL-07
Jun 19, 2023
Strategic Partnership
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
Hovione
PR-M03-23-06
Mar 22, 2023
ADCS
Improving the Therapeutic Index of ADCs with a Peptide Linker Technology
Philipp Spycher
Araris Biotech AG
PAO-07-022-CL-01
Jul 07, 2022
Cell Line Development
Wheeler Bio Integrates the Solentim® Ecosystem by Advanced Instruments to Deliver the Highest Level of Consistency Across Their Cell Line Development Workflow
Advanced Instruments
PR-M06-22-04
Jun 14, 2022
Immuno-Oncology
Tuning the Myeloid Compartment with a Best-in-Class CDMO
Kiren Khanduga; Alicia Levey, Ph.D.
Pionyr Immunotherapeutics
PAO-06-022-CL-04
Jun 06, 2022
Digitalization
Reducing Time to IND, Increasing Quality, and Building Trust through Shared Data
David Alvaro, Ph.D.; Christa Short; Jesse McCool, Ph.D.; Lance Johnson; Markus Gershater, Ph.D.; Michael Sokolov, Ph.D.; Yuk Chun Chiu, M.S.E.; Guy Levy-Yurista, Ph.D.; David Schmidt, M.B.A., M.Sc.
Pharma's Almanac
PAO-05-022-CL-01
May 18, 2022
Chemistry
Strategic Partnerships for Pharma's Chemistry Needs
Therachem Laboratories
PAO-05-22-R250-04
May 12, 2022
Strategic Partnership
DFE Pharma, Harro Höfliger, and Sterling Partner in “INTO” to Provide Formulation Services for Respiratory Products
DFE Pharma
PR-M03-22-16
Mar 29, 2022
Strategic Partnership
Chimeric Partners With Be The Match BioTherapies® To Advance CHM 1101 (CLTX CAR T)
Chimeric Therapeutics
PR-M03-22-07
Mar 17, 2022
Strategic Partnership
Hovione and Zerion Pharma Announce a Strategic Partnership to Market the Dispersome® Technology Platform
Hovione
PR-M02-22-19
Feb 22, 2022
Strategic Partnership
eTheRNA Announces Research Agreement with Merck KGaA, Darmstadt, Germany to Access mRNA Technologies
eTheRNA Immunotherapies NV
PR-M02-22-02
Feb 03, 2022
mRNA Manufacturing
Serving an Accelerated Market with mRNA Production
Mark Bamforth
Arranta Bio
PAO-11-21-CL-06
Dec 08, 2021
Bispecific Antibodies
A Small Biotech with Two Complex Bispecific Antibody Candidates Benefits from Lonza’s Blend of Expertise and Flexibility
Craig Parker
PAO-12-21-CL-01
Dec 03, 2021
